Cambridge, MA, United States of America

Renato A Chiarella

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Renato A. Chiarella

Introduction

Renato A. Chiarella is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. He holds a total of four patents, showcasing his expertise and innovative spirit in developing advanced drug formulations.

Latest Patents

Chiarella's latest patents focus on the crystallization process of aripiprazole derivatives, particularly in extended-release formulations for the treatment of schizophrenia. His work includes processes for providing depot injections of recrystallized aripiprazole lauroxil, where the particles have a surface area ranging from about 0.50 to about 3.3 m/g. Additionally, he has developed crystals of aripiprazole lauroxil produced by these innovative processes.

Career Highlights

Throughout his career, Renato A. Chiarella has worked with prominent companies in the pharmaceutical industry, including Alkermes Pharma Ireland Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in medication delivery systems.

Collaborations

Chiarella has collaborated with notable professionals in his field, including Wilfredo Morales and Tarek A. Zeidan. These partnerships have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Renato A. Chiarella's work exemplifies the intersection of innovation and pharmaceutical science. His contributions to the crystallization processes for aripiprazole derivatives highlight his commitment to improving treatment options for schizophrenia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…